VCRE (Vicore Pharma Holding AB) Other Current Receivables: $1.55 Mil (As of Mar. 2026)


VCRE Vicore Pharma Holding AB VCRE
13 GF Score
Price $15.03
! 5 Warning Signs
View Full Analysis

What is Vicore Pharma Holding AB Other Current Receivables?

Vicore Pharma Holding AB VCRE -7.54% 13 Other Current Receivables is $1.55 Mil as of Mar. 2026. GuruFocus rates VCRE with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

Vicore Pharma Holding AB's Other Current Receivables for the quarter that ended in Mar. 2026 was $1.55 Mil.

Vicore Pharma Holding AB's quarterly Other Current Receivables declined from Sep. 2025 ($3.15 Mil) to Dec. 2025 ($1.75 Mil) but then stayed the same from Dec. 2025 ($1.75 Mil) to Mar. 2026 ($1.55 Mil).

Vicore Pharma Holding AB's annual Other Current Receivables increased from Dec. 2023 ($0.32 Mil) to Dec. 2024 ($1.80 Mil) but then declined from Dec. 2024 ($1.80 Mil) to Dec. 2025 ($1.75 Mil).

Vicore Pharma Holding AB Other Current Receivables Related Terms

Vicore Pharma Holding AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Vicore Pharma Holding AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicore Pharma Holding AB Other Current Receivables Chart

Vicore Pharma Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.21 0.32 1.80 1.75

Vicore Pharma Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.22 3.99 3.15 1.75 1.55
VCRE
13GF Score
Vicore Pharma Holding AB VCRE
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vicore Pharma Holding AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $1.55 Mil mean?
Vicore Pharma Holding AB (VCRE) has a Other Current Receivables of $1.55 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Vicore Pharma Holding AB and its competitors.
Is Vicore Pharma Holding AB's Other Current Receivables too high?
Vicore Pharma Holding AB's current Other Current Receivables is $1.55 Mil. Overall, Vicore Pharma Holding AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Vicore Pharma Holding AB's Other Current Receivables compare to ?
Vicore Pharma Holding AB's Other Current Receivables of $1.55 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Vicore Pharma Holding AB and its competitors. Vicore Pharma Holding AB's current Other Current Receivables is $1.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicore Pharma Holding AB stock overvalued right now?
Vicore Pharma Holding AB (VCRE) has a current Other Current Receivables of $1.55 Mil. The current Other Current Receivables is $1.55 Mil. Vicore Pharma Holding AB's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Vicore Pharma Holding AB (VCRE), the current Other Current Receivables is $1.55 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicore Pharma Holding AB Business Description

Comparable Companies
Other Exchanges VICO:Sweden6Y4:Germany
Address Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
13GF Score

Get the complete analysis for VCRE

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.03
Price